Cibus, Inc. (CBUS) Stock Analysis & Investment Frameworks
Cibus, Inc. (CBUS) stock analysis on Invetso. Review Cibus, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Cibus, Inc. Company Overview
- Exchange: NASDAQ
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Cibus, Inc. Key Financial Metrics
- Market Cap: $90.19M
- Revenue: $3.64M
- ROE: -320.60%
- ROIC: -17.82%
- Dividend Yield: N/A
About Cibus, Inc.
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cibus, Inc. Investment Frameworks
Invetso analyzes Cibus, Inc. (CBUS) across the following frameworks:
- Cibus, Inc. 10Y Growth Potential
- Cibus, Inc. Scenario Analysis
- Cibus, Inc. Risks & Opportunities
- Cibus, Inc. Economic Moat
- Cibus, Inc. Business Model
- Cibus, Inc. Management
- Cibus, Inc. SWOT Analysis
- Cibus, Inc. Porter's 5 Forces
- Cibus, Inc. PESTLE Analysis
- Cibus, Inc. ESG Analysis